148 related articles for article (PubMed ID: 29571888)
1. Evaluation of the quality of life in patients followed for differentiated cancer of the thyroid.
Haraj NE; Bouri H; El Aziz S; Nani S; Habti N; Chadli A
Ann Endocrinol (Paris); 2019 Feb; 80(1):26-31. PubMed ID: 29571888
[TBL] [Abstract][Full Text] [Related]
2. [Anxiety and depression in patients treated for differentiated thyroid microcarcinoma].
Haraj NE; El Aziz S; Chadli A
Pan Afr Med J; 2020; 35():133. PubMed ID: 32655747
[TBL] [Abstract][Full Text] [Related]
3. Measurement and Variation in Estimation of Quality of Life Effects of Patients Undergoing Treatment for Papillary Thyroid Carcinoma.
Lubitz CC; De Gregorio L; Fingeret AL; Economopoulos KP; Termezawi D; Hassan M; Parangi S; Stephen AE; Halpern EF; Donelan K; Swan JS
Thyroid; 2017 Feb; 27(2):197-206. PubMed ID: 27824301
[TBL] [Abstract][Full Text] [Related]
4. Illness perception in patients with differentiated epithelial cell thyroid cancer.
Hirsch D; Ginat M; Levy S; Benbassat C; Weinstein R; Tsvetov G; Singer J; Shraga-Slutzky I; Grozinski-Glasberg S; Mansiterski Y; Shimon I; Reicher-Atir R
Thyroid; 2009 May; 19(5):459-65. PubMed ID: 19415995
[TBL] [Abstract][Full Text] [Related]
5. Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy.
Lang BH; Wong IO; Wong KP; Cowling BJ; Wan KY
Surgery; 2012 Jun; 151(6):844-50. PubMed ID: 22341041
[TBL] [Abstract][Full Text] [Related]
6. Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma.
Scheffel RS; Zanella AB; Dora JM; Maia AL
Thyroid; 2016 Nov; 26(11):1623-1629. PubMed ID: 27549175
[TBL] [Abstract][Full Text] [Related]
7. Quality of life-in patients with differentiated thyroid cancer at the general endocrinology clinics of the University Hospital of Puerto Rico.
Vega-Vázquez MA; Gonzalez-Rodriguez L; Santiago-Rodríguez EJ; Garcés-Domínguez A; Shum LM; Tírado-Gómez M; Ramírez-Vick M
Bol Asoc Med P R; 2015; 107(1):25-31. PubMed ID: 26035981
[TBL] [Abstract][Full Text] [Related]
8. Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.
Pacini F; Ladenson PW; Schlumberger M; Driedger A; Luster M; Kloos RT; Sherman S; Haugen B; Corone C; Molinaro E; Elisei R; Ceccarelli C; Pinchera A; Wahl RL; Leboulleux S; Ricard M; Yoo J; Busaidy NL; Delpassand E; Hanscheid H; Felbinger R; Lassmann M; Reiners C
J Clin Endocrinol Metab; 2006 Mar; 91(3):926-32. PubMed ID: 16384850
[TBL] [Abstract][Full Text] [Related]
9. Quality of life and anxiety in adolescents with differentiated thyroid cancer.
Oren A; Benoit MA; Murphy A; Schulte F; Hamilton J
J Clin Endocrinol Metab; 2012 Oct; 97(10):E1933-7. PubMed ID: 22791758
[TBL] [Abstract][Full Text] [Related]
10. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
11. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
[TBL] [Abstract][Full Text] [Related]
12. Low- or high-dose radioiodine remnant ablation for differentiated thyroid carcinoma: a meta-analysis.
Cheng W; Ma C; Fu H; Li J; Chen S; Wu S; Wang H
J Clin Endocrinol Metab; 2013 Apr; 98(4):1353-60. PubMed ID: 23436920
[TBL] [Abstract][Full Text] [Related]
13. Five-year longitudinal evaluation of quality of life in a cohort of patients with differentiated thyroid carcinoma.
Giusti M; Melle G; Fenocchio M; Mortara L; Cecoli F; Caorsi V; Ferone D; Minuto F; Rasore E
J Zhejiang Univ Sci B; 2011 Mar; 12(3):163-73. PubMed ID: 21370500
[TBL] [Abstract][Full Text] [Related]
14. [Draft of the best medical treatment in patients with low-risk thyroid cancer].
Vlček P; Nováková D; Vejvalka J; Zimák J; Křenek M; Vošmiková K; Smutný S; Bavor P; Astl J; Lukáš J
Vnitr Lek; 2015 Sep; 61(9):769-77. PubMed ID: 26465275
[TBL] [Abstract][Full Text] [Related]
15. Differentiated thyroid cancer: effect on quality of life, depression, and anxiety.
Helvacı BC; Yalçın MM; Yalcın ŞNG; Arslan E; Altinova AE; Törüner FB
Hormones (Athens); 2023 Sep; 22(3):367-374. PubMed ID: 37084015
[TBL] [Abstract][Full Text] [Related]
16. Differentiated thyroid carcinoma: Incremental diagnostic value of
Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
[TBL] [Abstract][Full Text] [Related]
17. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
Jarzab B; Handkiewicz-Junak D; Wloch J
Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
[TBL] [Abstract][Full Text] [Related]
18. Clinical predictors of quality of life in patients with initial differentiated thyroid cancers.
Almeida JP; Vartanian JG; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):342-6. PubMed ID: 19380354
[TBL] [Abstract][Full Text] [Related]
19. Health-related Quality of Life, depression and anxiety in thyroid cancer patients.
Tagay S; Herpertz S; Langkafel M; Erim Y; Bockisch A; Senf W; Görges R
Qual Life Res; 2006 May; 15(4):695-703. PubMed ID: 16688502
[TBL] [Abstract][Full Text] [Related]
20. Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role?
Silva-Vieira M; Carrilho Vaz S; Esteves S; Ferreira TC; Limbert E; Salgado L; Leite V
Thyroid; 2017 Aug; 27(8):1068-1076. PubMed ID: 28614983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
